Analysis of Frailty Syndrome Within the Framework of the Innovation Fund Project PRÄP-GO (ANA-PRÄP-GO)
NCT ID: NCT04880824
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
693 participants
OBSERVATIONAL
2021-05-19
2025-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Amendment vote of 08/05/2024: Recruitment extension of Non-frail surgical control group (NFC cohort) until August 31, 2025.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Preoperative Frailty Assessment Tools
NCT06889545
Hand Grip Strength as a Marker of Frailty in Surgical Patients
NCT02966470
Frailty Assessment in Vascular Hot Clinic Setting - Feasibility and Prognostic Value
NCT06040658
Frailty Screening in the Swedish Emergency Department Setting
NCT04877028
Preoperative Frailty Assessment With Ultrasound in Elderly Patients
NCT05438628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The groups of participants in this accompanying program ANA-PRÄP-GO are:
* Randomized study patients with a frailty syndrome of the intervention study PRÄP-GO (PG cohort)
* Non-frail surgical control group (NFC cohort)
* Non-surgical comparison group (NO cohort)
* Participants with health professions (GB cohort)
Additionally, relatives of the patients can be included.
Subprojects are included to reflect research questions of interest in sub groups:
* Success of endoprosthetic implants (clinical outcome and gait pattern after total hip arthroplasty and total knee arthroplasty in frail patients)
* Functional treatment outcome and health-related quality of life after elective spinal surgery in the PG cohort, in the NFC cohort, and in the NO cohort
* Hemodynamic evaluation in patients of the PG and NFC cohort with preoperative abnormal cardiovascular function
* Establishment of a German standard database for 14 CANTAB tests by CANTAB Connect technology
* Aggregated evaluation of the cognitive data of different surgical cohorts from studies carried out at the department of anesthesiology to describe domain-specific changes in the perioperative course
* Perspectives of different health professional groups regarding barriers and facilitators in the implementation of a prehabilitation program and necessary changes in skill, organizational and management, and communication in an interdisciplinary setting
* Perspectives of patients and significant others regarding the organizational pathway of the prehabilitation program
* Frequency, pathophysiology and trajectory of muscle weakness as well as functional impairments of patients admitted to intensive care units of the PG and NFC cohort and their long-term outcomes.
* The gut microbiome as a potential risk factor for perioperative neurocognitive disorders (PNDs) in the elderly
* Evaluation of nutrition data in all cohorts (e.g. adherence to mediterranean diet, nutrition habits, nutritional status, dental status etc.)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PG cohort
800 randomized surgical study patients with a frailty syndrome (Pre-frail and frail) of the intervention study PRÄP-GO (PG cohort). 400 study patients receive the intervention and 400 study patients receive standard of care.
Prehabilitation- new form of care
The participants in the intervention group take part in a shared decision-making (SDM) conference to plan the intervention. The therapeutic content of the prehabilitation is defined individually for each patient in the SDM conference. Prehabilitation will be a structured and individually tailored 3-week program.
NFC cohort
400 non-frail surgical control group (NFC cohort)
No interventions assigned to this group
NO cohort
300 non-operative control group (NO cohort)
No interventions assigned to this group
GB cohort
Skill-Change-Management: a maximum of 30 coworkers and analysis of guiding principle: to a maximum of 35 patients, 30 relatives and 45 coworkers
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prehabilitation- new form of care
The participants in the intervention group take part in a shared decision-making (SDM) conference to plan the intervention. The therapeutic content of the prehabilitation is defined individually for each patient in the SDM conference. Prehabilitation will be a structured and individually tailored 3-week program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient capable of giving consent or existing legal guardian in the case of patients not capable of giving consent
* Patient capable of giving consent or existing legal guardian in the case of patients not capable of giving consent
* Age ≥ 70 years
* Elective surgery planned
* Expected anesthesia duration\> 60 min
* No frailty syndrome (0 positive out of 5 standardized parameters) according to the physical frailty phenotype (Fried et al., 2001)
\- Age ≥ 70 years
* No elective surgery planned
* No surgery within 6 months prior to study enrollment
* Member of a patient in the PRÄP-GO cohort
* Age ≥ 18 years
Exclusion criterion
\- Language barrier
Exclusion Criteria
NFC cohort:
* Severe cardiac or pulmonary disease (NYHA IV, Gold IV)
* Intracranial interventions
* Moribund patients (palliative situation)
* Patients with a neuropsychiatric clinical picture or severe hearing and / or visual acuity impairment (not compensated by visual or hearing aids), which limit the performance of the neurocognitive tests
* Insufficient language skills
* Participation in another interventional rehabilitation study or a study according to the German Drug Law or the medical Device Law that has not been approved by the study leader (Exception: parallel participation in adjuvant therapy study).
NO cohort:
GB cohort:
Inclusion criterion
\- Doctor, nurse or therapist from the cooperation partners of PRAEP-GO who were involved in the project
Exclusion criterion
\- Language barrier
Relatives:
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Spies
Head of the Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Spies, MD, Prof.
Role: STUDY_DIRECTOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Praxis Prof. Dr med. Ulrich Schwantes
Schwante, Brandenburg, Germany
Charité-Universitätsmedizin Berlin, Department of Physical Medicine
Berlin, , Germany
Praxis Landgraf
Berlin, , Germany
Department of Anesthesiology and Operative Intensive Care Medicine (CBF)
Berlin, , Germany
Department of Anesthesiology and Intensive Care Medicine, Charité - University Medicine
Berlin, , Germany
Paul Gerhard Diakonie - Evangelisches Waldkrankenhaus Spandau
Berlin, , Germany
Paul Gerhard Diakonie - Evangelisches Krankenhaus Hubertus
Berlin, , Germany
Paul Gerhard Diakonie - Martin-Luther-Krankenhaus
Berlin, , Germany
Auguste-Viktoria-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH
Berlin, , Germany
CARITAS Klinik Maria Heimsuchung
Berlin, , Germany
Dominikus-Krankenhaus
Berlin, , Germany
Humboldt-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH
Berlin, , Germany
Klinikum im Friedrichshain - Vivantes - Netzwerk für Gesundheit GmbH
Berlin, , Germany
Sankt Jospeph Krankenhaus
Berlin, , Germany
Unfallkrankenhaus Berlin
Berlin, , Germany
Universitätsklinikum Mannheim GmbH
Berlin, , Germany
Wenckebach-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH
Berlin, , Germany
Carl-Thiem-Klinikum
Cottbus, , Germany
Werner Forßmann-Krankenhaus
Eberswalde, , Germany
Klinikum Frankfurt Oder GmbH
Frankfurt (Oder), , Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, , Germany
Asklepios Klinikum Harburg
Harburg, , Germany
Sana Kliniken Sommerfeld
Kremmen, , Germany
Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Universität zu Lübeck
Lübeck, , Germany
Klinikum der Universität München, LMU Campus Großhadern
München, , Germany
Klinikum rechts der Isar - Technische Universität München
München, , Germany
München Klinik Bogenhausen
München, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANA-PRAEP-GO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.